potentially ending a decade-long drought in new therapies for the debilitating skin condition also known as chronic hives. Xolair (omalizumab) has been around since the early 2000s as a treatment ...
Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...
Chronic hives sufferers can breathe a sigh of relief as a recent study has found that a drug already used to treat moderate to severe allergic asthma can help them. Patients who develop itchy ...
CSU is a chronic skin condition that causes sudden and debilitating hives and persistent itch, which can impact quality of life. This positive trial confirms results from Study A, the first Phase ...